| New insights into IL-12-mediated tumor suppression S Tugues, SH Burkhard, I Ohs, M Vrohlings, K Nussbaum, J Vom Berg, ... Cell Death & Differentiation 22 (2), 237-246, 2015 | 540 | 2015 |
| Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline J Vom Berg, S Prokop, KR Miller, J Obst, RE Kälin, I Lopategui-Cabezas, ... Nature medicine 18 (12), 1812-1819, 2012 | 472 | 2012 |
| IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46 M Eisenring, J Vom Berg, G Kristiansen, E Saller, B Becher Nature immunology 11 (11), 1030-1038, 2010 | 247 | 2010 |
| Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection J Vom Berg, M Vrohlings, S Haller, A Haimovici, P Kulig, A Sledzinska, ... Journal of Experimental Medicine 210 (13), 2803-2811, 2013 | 217 | 2013 |
| A βPix–Pak2a signaling pathway regulates cerebral vascular stability in zebrafish J Liu, SD Fraser, PW Faloon, EL Rollins, J Vom Berg, O Starovic-Subota, ... Proceedings of the National Academy of Sciences 104 (35), 13990-13995, 2007 | 132 | 2007 |
| Enzymatic dissociation induces transcriptional and proteotype bias in brain cell populations D Mattei, A Ivanov, M van Oostrum, S Pantelyushin, J Richetto, F Mueller, ... International journal of molecular sciences 21 (21), 7944, 2020 | 93 | 2020 |
| Rationale for combining bispecific T cell activating antibodies with checkpoint blockade for cancer therapy S Kobold, S Pantelyushin, F Rataj, J Vom Berg Frontiers in oncology 8, 285, 2018 | 92 | 2018 |
| Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease MA Khosravi, M Abbasalipour, JP Concordet, J Vom Berg, S Zeinali, ... European journal of pharmacology 854, 398-405, 2019 | 78 | 2019 |
| Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models MA Schneider, L Heeb, MM Beffinger, S Pantelyushin, M Linecker, L Roth, ... Science translational medicine 13 (611), eabc8188, 2021 | 55 | 2021 |
| Bispecific antibodies enable synthetic agonistic receptor-transduced T cells for tumor immunotherapy CH Karches, MR Benmebarek, ML Schmidbauer, M Kurzay, R Klaus, ... Clinical Cancer Research 25 (19), 5890-5900, 2019 | 35 | 2019 |
| Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer D Alonso-Miguel, G Valdivia, D Guerrera, MD Perez-Alenza, ... Journal for immunotherapy of cancer 10 (3), 2022 | 26 | 2022 |
| Cross-reactivity and functionality of approved human immune checkpoint blockers in dogs S Pantelyushin, E Ranninger, D Guerrera, G Hutter, C Maake, ... Cancers 13 (4), 785, 2021 | 20 | 2021 |
| T cell-specific inactivation of mouse CD2 by CRISPR/Cas9 J Beil-Wagner, G Dössinger, K Schober, J Vom Berg, A Tresch, M Grandl, ... Scientific reports 6 (1), 21377, 2016 | 20 | 2016 |
| Microglia-centered combinatorial strategies against glioblastoma TA Martins, P Schmassmann, T Shekarian, JL Boulay, MF Ritz, ... Frontiers in immunology 11, 571951, 2020 | 18 | 2020 |
| Bone marrow chimeras—a vital tool in basic and translational research FM Ferreira, P Palle, J Vom Berg, P Prajwal, JD Laman, T Buch Journal of Molecular Medicine 97, 889-896, 2019 | 17 | 2019 |
| TMBIM5 loss of function alters mitochondrial matrix ion homeostasis and causes a skeletal myopathy L Zhang, F Dietsche, B Seitaj, L Rojas-Charry, N Latchman, D Tomar, ... Life science alliance 5 (10), 2022 | 16 | 2022 |
| OMIP‐065: dog immunophenotyping and T‐cell activity evaluation with a 14‐color panel S Pantelyushin, E Ranninger, R Bettschart‐Wolfensberger, J Vom Berg Cytometry Part A 97 (10), 1024-1027, 2020 | 16 | 2020 |
| Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy B Becher, J Vom Berg US Patent App. 14/350,362, 2015 | 16 | 2015 |
| In vivo imaging of hypoxia-inducible factor regulation in a subcutaneous and orthotopic GL261 glioma tumor model using a reporter gene assay S Bürgi, A Seuwen, R Keist, J Vom Berg, J Grandjean, M Rudin Molecular imaging 13 (9), 7290.2014. 00029, 2014 | 14 | 2014 |
| Enabling comprehensive optogenetic studies of mouse hearts by simultaneous opto-electrical panoramic mapping and stimulation M Rieger, C Dellenbach, J Vom Berg, J Beil-Wagner, A Maguy, S Rohr Nature communications 12 (1), 5804, 2021 | 10 | 2021 |
